Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=29391334
&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests
in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215
Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 245.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 245.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 245.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 245.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 245.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 245.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\29391334
.jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117 Turk+J+Haematol
2018 ; 35
(1
): 1-11
Nephropedia Template TP
gab.com Text
Twit Text FOAVip
Twit Text #
English Wikipedia
Hematolojik Kanserleri Olan ?nvaziv Mantar Enfeksiyonlu Hastalar: Dirençli
Patojenlerin Ortaya Ç?k??? ve Yeni Antifungal Tedaviler
#MMPMID29391334
Gamaletsou MN
; Walsh TJ
; Sipsas NV
Turk J Haematol
2018[Mar]; 35
(1
): 1-11
PMID29391334
show ga
Invasive fungal infections caused by drug-resistant organisms are an emerging
threat to heavily immunosuppressed patients with hematological malignancies.
Modern early antifungal treatment strategies, such as prophylaxis and empirical
and preemptive therapy, result in long-term exposure to antifungal agents, which
is a major driving force for the development of resistance. The extended use of
central venous catheters, the nonlinear pharmacokinetics of certain antifungal
agents, neutropenia, other forms of intense immunosuppression, and drug
toxicities are other contributing factors. The widespread use of agricultural and
industrial fungicides with similar chemical structures and mechanisms of action
has resulted in the development of environmental reservoirs for some
drug-resistant fungi, especially azole-resistant Aspergillus species, which have
been reported from four continents. The majority of resistant strains have the
mutation TR34/L98H, a finding suggesting that the source of resistance is the
environment. The global emergence of new fungal pathogens with inherent
resistance, such as Candida auris, is a new public health threat. The most common
mechanism of antifungal drug resistance is the induction of efflux pumps, which
decrease intracellular drug concentrations. Overexpression, depletion, and
alteration of the drug target are other mechanisms of resistance. Mutations in
the ERG11 gene alter the protein structure of C-demethylase, reducing the
efficacy of antifungal triazoles. Candida species become echinocandin-resistant
by mutations in FKS genes. A shift in the epidemiology of Candida towards
resistant non-albicans Candida spp. has emerged among patients with hematological
malignancies. There is no definite association between antifungal resistance, as
defined by elevated minimum inhibitory concentrations, and clinical outcomes in
this population. Detection of genes or mutations conferring resistance with the
use of molecular methods may offer better predictive values in certain cases.
Treatment options for resistant fungal infections are limited and new drugs with
novel mechanisms of actions are needed. Prevention of resistance through
antifungal stewardship programs is of paramount importance.
|Antifungal Agents/pharmacology/*therapeutic use
[MESH]